Professor Peter Nash’s research interests include metabolic bone disease and novel therapeutics.

Professor Nash’s group at the Rheumatology Research Unit have been involved with clinical trials concerning all modern targeted biologic therapies and osteoporosis therapies.

Professor Nash has published over 200 peer-reviewed publications - journal articles, conference papers and 5 book chapters. He acts as a peer reviewer for a number of clinical research journals while being on the editorial boards of Annals of the Rheumatic Diseases and RMD Open. Therefore, he is recognised as a research leader in the area of rheumatology.